Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2

Status

Completed 6Terminated 4Unknown 2Withdrawn 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 31Gastrointestinal 14Tumor-Agnostic 7Thoracic 6Other solid neoplasm 5Head & Neck 5CNS 4Sarcoma 3Endocrine 3Dermatologic 3Gynecologic 2Breast 2Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 2Mesothelioma, Malignant 1Mesothelioma 1Carcinoma 1Advanced Non-small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Axitinib × Thoracic × Clear all
NCT05420220 2026-05-28

Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 2 Completed
95 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT01211275 2017-02-28

N08CPA

The Netherlands Cancer Institute

Phase 1/2 Completed
32 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00768755 2015-10-28

Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer

Pfizer

Phase 1/2 Completed
180 enrolled 13 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00600821 2013-11-08

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Pfizer

Phase 2 Completed
118 enrolled 12 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00735904 2013-01-03

Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

Pfizer

Phase 2 Completed
38 enrolled 9 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00094094 2012-06-26

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Pfizer

Phase 2 Completed
32 enrolled 9 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡